D. Bergin (Dublin, Ireland), C. Bingle (Sheffield, United Kingdom), G. John (Munich, Germany), T. P. Carroll (Dublin, Ireland)
LATE-BREAKING ABSTRACT: Procalcitonin as a diagnostic marker in acute exacerbation of COPD
K. Hassaan, M. Mohamed, E. Ramadan, M. Hashim, S. Sharaf (Riyadh, Saudi Arabia)
|  |
Transforming growth factor-beta1 (TGF-β1) expression is related to reticular basement membrane (Rbm) hypervascularity in smokers and COPD
S.S. Sohal, A. Soltani, D. Reid, S. Weston, H.K. Muller, R. Wood-Baker, E.H. Walters (Hobart, Brisbane, Australia)
| |
Blood outgrowth endothelial cells are senescent and dysfunctional in COPD due to increased DNA damage; implications for endothelial dysfunction
K. Paschalaki, R. Starke, N. Mercado, V. Gorgoulis, A.M. Randi, P.J. Barnes (London, United Kingdom; Athens, Greece)
| |
Increased levels of soluble intercellular adhesion molecule 1 in active smokers
E. Arellano-Orden, A. Montes-Worboys, C. Calero-Acuña, E. Marquez-Martin, P. Cejudo-Ramos, F. Ortega-Ruiz, J.L. Lopez-Campos (Seville, Madrid, Spain)
| |
Correlation between immunohistochemical CuZn-SOD expression and the histopathological features in small airways of patients with severe COPD
B.T. Olejnicka, S. Marklund, C. Andersson, M. Mori, A. Rubaj, C.G. Löfdahl, J. Erjefält (Trelleborg, Lund, Umeå, Sweden; Lublin, Poland)
| |
The impact of long-term tobacco smoking on circulating IL-16+ NK cells
A. Andersson, A. Bossios, C. Malmhäll, M. Sjöstrand, B. Houltz, I. Qvarfordt, A. Lindén (Gothenburg, Sweden)
| |
The dynamics of IV-type collagen contents in BALF of patients with COPD
M. Ostrovskyy, I. Savelikhina, O. Varunkiv, M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine)
| |
Senescence marker protein-30 decreases oxidative stress in human lungs of smokers with chronic obstructive pulmonary disease
T. Fan, B. Mao, G. Wang (Chengdu, China)
|  |
Relation of inflammatory process with COPD phenotype
S. Atis Nayci, E.S. Özgür, C. Özge, A. Ilvan (Mersin, Turkey)
| |
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD
E. Papakonstantinou, M. Tamm, M. Roth, D. Stolz (Thessaloniki, Greece; Basel, Switzerland)
| |
Enhanced IL-6 and CCL3 activity in COPD
A. Ravi, S. Khurana, J. Plumb, G. Booth, M. Catley, E. Smith, L. Healy, J. Vestbo, D. Singh (Slough, United Kingdom)
| |
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
C. Calero, E. Arellano, A. Montes-Worboys, V. Sanchez, D. Tobar, N. Moreno, E. Barrot, J.L. Lopez-Campos (Seville, Madrid, Spain)
| |
Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD
M. Vaitkus, S. Lavinskiene, K. Bieksiene, J. Jeroch, R. Sakalauskas (Kaunas, Lithuania)
| |
Elevated sputum complement factor H levels in COPD: Relationship with disease severity
Z. Weiszhár, G. Gálffy, Z. Lázár, A. Bikov, G. Losonczy, I. Horváth (Budapest, Hungary)
| |
Stage-dependent regulation of brain-derived neurotrophic factor and transforming growth factor-β1 in patients with COPD
P. Stoll, U. Wuertemberger, K. Bratke, C. Zingler, J.C. Virchow, M. Lommatzsch (Rostock, Germany)
| |
IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD
K. Sysoev (St. Petersburg, Russian Federation)
| |
C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
A. Montes-Worboys, C. Calero-Acuña, E. Arellano-Orden, B. Rojano, J.L. Lopez-Villalobos, A. Blanco, V. Sanchez-López, D. Tobar, J.L. Lopez-Campos (Seville, Madrid, Spain)
| |
T cell chemokine receptor expression in COPD
H. Forsslund, M. Mikko, B. Engvall, J. Grunewald, A. Wheelock, J. Wahlström, M. Sköld (Stockholm, Sweden)
| |
Roflumilast-N-oxide exerts anti-remodelling potencies in COPD patients in vitro
C. Lambers, M. Roth, H. Tenor, E. Hofbauer, V. Petkov, L.H. Block (Vienna, Austria; Basel, Switzerland; Konstanz, Germany)
| |